Physician profile
Timothy Mcgraw
NPI 1265433494
$2,064.20
in general payments reported to CMS, 2019-2025
20 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $16.92 · 2021: $333 · 2022: $610 · 2023: $259 · 2024: $488 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,081.75 | 2019-2025 | |
| Ucb, INC. | $139.52 | 2019-2023 | Cimzia |
| Novartis Pharmaceuticals Corporation | $131.01 | 2022-2024 | |
| Kerecis Limited | $110.74 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Amgen INC. | $98.75 | 2020-2023 | Otezla |
| Leo Pharma INC. | $78.19 | 2022-2024 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $62.60 | 2022-2024 | Sotyktu |
| Genzyme Corporation | $58.22 | 2019-2025 | |
| Janssen Biotech, INC. | $56.87 | 2021-2023 | Tremfya |
| Arcutis Biotherapeutics, INC. | $44.17 | 2025 | Zoryve |
| Epi Health, LLC | $34.93 | 2022 | |
| Galderma Laboratories, L.P. | $30.02 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.34 | 2023 | Libtayo |
| Dusa Pharmaceuticals, INC. | $20.20 | 2019 | |
| Nabriva Therapeutics, Plc | $19.04 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.78 | 2022 | |
| Celgene Corporation | $16.30 | 2019 | |
| Strata Skin Sciences, INC. | $15.53 | 2022 | |
| Lilly USA, LLC | $12.10 | 2021 | |
| Prugen, INC. Pharmaceuticals | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mcgraw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.